×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
SAFE, EFFECTIVE AND AFFORDABLE MEDICINAL PRODUCTS FOR A GLOBAL POPULATION
Session Chair(s)
Marijke Pubben
Independant Pharmaceutical Consultant
Pubben Consulting B.V., Netherlands
Improving Site Selection and Regulatory Transparency through Global Infrastructure Mapping and Collaborative Analytics
Learning Objective : Understand how new guidances from FDA and EMA related to foreign clinical trials will impact sponsors on site selection for global trials. Learn how mapping global clinical research infrastructure can help clinical operations select sites under new regulatory guidances.
Speaker(s)
Building a Global Quality Culture
Marijke Pubben
Pubben Consulting B.V., Netherlands
Independant Pharmaceutical Consultant
International Cooperation on GxP/GCP Inspections
Tor Graberg, MS
Medical Products Agency (MPA), Sweden
Head of Inspections Unit
Improving Site Selection and Regulatory Transparency through Global Infrastructure Mapping and Collaborative Analytics
Gustavo Kesselring, MD
KING´S COLLEGE LONDON, Brazil
Senior Visiting Lecturer
Have an account?